Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients
Open Access
- 1 January 1998
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 7 (1) , 3-6
- https://doi.org/10.1191/096120398678919624
Abstract
We report a 10-year follow-up on 52 patients with raised levels of anticardiolipin antibodies (aCL) who were first seen at our tertiary referral centre in 1986. The clinical and serological features of these 52 patients are described. Thirty-one patients had the antiphospholipid syndrome (APS) in 1986. Nine of these patients (29%) had further thrombotic events during the follow-up period. Of the other 21 aCL positive patients without clinical manifestations of APS, 11 (52%) developed the syndrome over this period. Five patients (10%) died during the follow-up. Close monitoring of patients with connective tissue diseases and aCL is essential as the likelihood of developing antiphospholipid syndrome is high.Keywords
This publication has 8 references indexed in Scilit:
- Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the italian registryThe American Journal of Medicine, 1996
- Antiphospholipid antibodies and antiphospholipid syndromeCurrent Opinion in Rheumatology, 1995
- The Management of Thrombosis in the Antiphospholipid-Antibody SyndromeNew England Journal of Medicine, 1995
- Anticardiolipin Wet Workshop Report:Fifth International Symposium on Antiphospholipid AntibodiesAmerican Journal of Clinical Pathology, 1994
- Comparison of the primary and secondary antiphospholipid syndrome: A European multicenter study of 114 patientsThe American Journal of Medicine, 1994
- The antiphospholipid syndrome: ten years onThe Lancet, 1993
- WHICH PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODY SHOULD BE TREATED AND HOW?Rheumatic Disease Clinics of North America, 1993
- Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous ThrombosisAnnals of Internal Medicine, 1992